Valerie E. Moberg

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Jeffrey S. Weber, Geoffrey T. Gibney, Ragini R. Kudchadkar et al. · Cancer Immunology Research · 2016 · 248 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Novel Toll-like Receptor 2 Ligands for Targeted Pancreatic Cancer Imaging and Immunotherapy

Amanda S. Huynh, Woo Jin Chung, Hyun-Il Cho et al. · Journal of Medicinal Chemistry · 2012 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Çiğdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso et al. · Clinical Cancer Research · 2019 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthesis and Characterization of a Melanoma-Targeted Fluorescence Imaging Probe by Conjugation of a Melanocortin 1 Receptor (MC1R) Specific Ligand

Narges K. Tafreshi, Xuan‐Yi Huang, Valerie E. Moberg et al. · Bioconjugate Chemistry · 2012 · 33 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Synthesis and Characterization of Time-resolved Fluorescence Probes for Evaluation of Competitive Binding to Melanocortin Receptors

Ramesh Alleti, Josef Vágner, Dilani C. Dehigaspitiya et al. · Bioorganic & Medicinal Chemistry · 2013 · 13 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16